✦ LIBER ✦
40 kDa peginterferon alfa-2A (PEGASYS®) as a prophylaxis against hepatitis C infection recurrence after liver transplantation (LT): preliminary results of a randomized multicenter trial: Cosme Manzarbeitia, Albert Einstein Medical Center, Philadelphia, PA; Lewis Tepermann, New York University Medical Center, New York, NY; Naga Chalasani, Indiana University Medical Center, Indianapolis, IN; Patricia Sheiner, Mount Sinai Medical Center, New York, NY; Russel Wiesner, The Mayo Clinic, Rochester, MN; Ian M Marks, Lucy Wynohradnyk, S. Chris Pappas, Roche Laboratories Inc, Nutley, NJ
- Book ID
- 118689316
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 189 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.